# FDA Inspection 714241 - Kaiser Permanente-Sunnyside Medical Center - March 14, 2011

Source: https://www.keypedia.com/records/fda_inspections/kaiser-permanente-sunnyside-medical-center/6a909a58-942b-4f8e-8477-45887262edb5
Source feed: FDA_Inspections

> FDA Inspection 714241 for Kaiser Permanente-Sunnyside Medical Center on March 14, 2011. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 714241
- Company Name: Kaiser Permanente-Sunnyside Medical Center
- Inspection Date: 2011-03-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1263925 - 2025-03-11](https://www.keypedia.com/records/fda_inspections/kaiser-permanente-sunnyside-medical-center/31f8ece6-3a52-400c-93a9-dc9a73a94593)
- [FDA Inspection 1263925 - 2025-03-11](https://www.keypedia.com/records/fda_inspections/kaiser-permanente-sunnyside-medical-center/04eba380-81e7-4d1d-a54f-983b01064d34)
- [FDA Inspection 1158929 - 2021-12-07](https://www.keypedia.com/records/fda_inspections/kaiser-permanente-sunnyside-medical-center/a16b6fbe-d47d-4f8a-bb9c-6be56f9a1e4b)
- [FDA Inspection 1158929 - 2021-12-07](https://www.keypedia.com/records/fda_inspections/kaiser-permanente-sunnyside-medical-center/92947025-ba5e-4bb0-a0a1-64a447f8ccf4)
- [FDA Inspection 1061266 - 2018-07-31](https://www.keypedia.com/records/fda_inspections/kaiser-permanente-sunnyside-medical-center/61382665-fed5-40d7-8931-6d5ab8b6cd23)

Company: https://www.keypedia.com/companies/kaiser-permanente-sunnyside-medical-center/cf6d8dd8-d0b5-4cdd-addc-9781bd1a43ee

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d